Executives On The Move: Moderna Names Senior Vice-President Of Government Engagement
Affimed, FibroGen And Redx Pharma Get New Board Members
Oasmia Pharmaceutical and Sierra Oncology appoint chief business officers, I-Mab a chief commercial officer, and AcuCort a CEO.
You may also be interested in...
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
Diffusion Pharmaceuticals and WPD Pharmaceuticals get new chief medical officers.
The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.